Clinical Trial Update: Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for cysteamine bitartrate delayed-release in pediatric NAFLD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• cysteamine bitartrate delayed-release (cysteamine bitartrate delayed-release)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-09-05